NCT00230074View on ClinicalTrials.gov

A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)

PHASE2CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

TCH346

Trial Locations (1)

07936

Novartis, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY